Recruiting Clinical Trials

Accelerated Hypofractionated Radiation Therapy Immediately Before Surgery in Treating Patients With Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Pleural Epithelioid Mesothelioma|Pleural Malignant Mesothelioma

Estimated Enrollment: 10

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 15-000487|NCI-2015-01736|JCCCID552|P30CA016042

Study First Received: November 2, 2015

Last Updated: August 8, 2016

Estimated Primary Completion Date: January 2018

 

Primary Outcome Measures:

Ability to accrue sufficient patients to draw conclusions about endpoints in a timely and expedient manner|Incidence of acute and subacute toxicity defined as grade 4 or 5 adverse events as assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0|Incidence of chronic toxicity as assessed by the NCI CTCAE version 4.0|Disease Specific Survival (DSS)|Local Control (LC)|Overall Survival (OS)|pathologic Complete Response Rate (pCR)

Sponsors and Collaborators:

Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT02672033

Leave a Reply

Call Now